What clinical pharmacology means to us. - Wikidata - awgldk - TriplyDB

What clinical pharmacology means to us.

What clinical pharmacology means to us.

http://www.wikidata.org/entity/Q35306859

about

The need to develop and sustain a symbiotic relationship between the industry and academia in the field of clinical pharmacology in India.

P2860

Q36855791-15ECD91E-AE4C-4B88-B36F-30587871C01D

P2860

What clinical pharmacology means to us.

http://www.wikidata.org/entity/Q35306859

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

What clinical pharmacology means to us.

@ast

What clinical pharmacology means to us.

@en

type

label

What clinical pharmacology means to us.

@ast

What clinical pharmacology means to us.

@en

prefLabel

What clinical pharmacology means to us.

@ast

What clinical pharmacology means to us.

@en

P1433

Q35306859-6AC2E3B3-CE42-4E38-A808-5145DBA52387

P1476

Q35306859-661F553F-5BA8-4F4C-94E2-7737DE079AF4

P2093

Q35306859-22ECDCAE-985B-4AFE-BEF9-20B5F2D0FDFB

Q35306859-5B86CBE1-DA1B-4FA7-A50D-7A94B6113FA8

P2860

Q35306859-016B3FC2-4B37-460B-94CA-9A4C6F14155E

Q35306859-06070480-DDA9-4877-B413-B6AC2C380B4D

Q35306859-0D496EA3-6111-4AE3-B58F-B91392FA29AA

Q35306859-321162A7-BC34-4C87-BD41-AB4FC8CE2E6B

Q35306859-4645B849-E8E6-4F61-B742-CB9D34FF9FCC

Q35306859-65FBB98A-D851-409C-9CA0-517F99C7A692

Q35306859-7997F3C4-FCF9-4DDE-83F4-053E89DC5534

Q35306859-7F0D24BA-0D6B-4B9F-B568-FAB3D30F8610

Q35306859-9EEC4F8D-F002-44D2-BF5A-D73C79A969C8

Q35306859-A21B3E61-FC1B-4874-99AF-00D77650AC44

P304

Q35306859-91909287-418C-435D-AE4F-50AF97CA5222

P31

Q35306859-34939E16-C988-4CFE-868A-85E160431E4A

P356

Q35306859-6D073750-505B-4F8F-B926-FC08EF5C92DB

P407

Q35306859-011D73A5-B4A5-4727-96B1-D73DFA1169B1

P433

Q35306859-9491EB73-638C-4534-AA96-498A9F1C0E27

P478

Q35306859-BBE24833-2B33-4EEB-A543-90C6E7762BD7

P577

Q35306859-8BE32857-4E7A-488A-8DA6-476B3C80F8C2

P698

Q35306859-C1E51478-1C2E-4004-88FB-729266C588A8

P932

Q35306859-5F04A730-10AA-4C1C-94B8-18107DA581E0

P356

0973-1229.27614

P1433

Mens Sana Monographs

P1476

What clinical pharmacology means to us.

@en

P2093

N Shafiq

http://www.w3.org/2001/XMLSchema#string

S Malhotra

http://www.w3.org/2001/XMLSchema#string

P2860

A strategy to reduce cardiovascular disease by more than 80%

The "Statinth" wonder of the world: a panacea for all illnesses or a bubble about to burst.

Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

Public welfare agenda or corporate research agenda?

Fluconazole-induced congenital anomalies in three infants.

The polypill and cardiovascular disease.

Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation.

A randomized trial to compare the efficacy, safety, cost and platelet aggregation effects of enoxaparin and unfractionated heparin (the ESCAPEU trial).

Oral simvastatin treatment in relapsing-remitting multiple sclerosis.

P304

184-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0973-1229.27614

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22013341

http://www.w3.org/2001/XMLSchema#string

P932

3190451

http://www.w3.org/2001/XMLSchema#string